The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Panevin T.S.

V.A. Nasonova Research Institute of Rheumatology;
Far Eastern State Medical University

Korotaeva T.V.

V.A. Nasonova Research Institute of Rheumatology

Zotkin E.G.

V.A. Nasonova Research Institute of Rheumatology

Glukhova S.I.

V.A. Nasonova Research Institute of Rheumatology

Salyanova E.P.

V.A. Nasonova Research Institute of Rheumatology

Samarkina E.Yu.

V.A. Nasonova Research Institute of Rheumatology

Diagnostic accuracy of the aging males’ symptoms questionnaire for screening androgen deficiency in patients with psoriatic arthritis

Authors:

Panevin T.S., Korotaeva T.V., Zotkin E.G., Glukhova S.I., Salyanova E.P., Samarkina E.Yu.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(5): 27‑33

Read: 566 times


To cite this article:

Panevin TS, Korotaeva TV, Zotkin EG, Glukhova SI, Salyanova EP, Samarkina EYu. Diagnostic accuracy of the aging males’ symptoms questionnaire for screening androgen deficiency in patients with psoriatic arthritis. Russian Journal of Preventive Medicine. 2025;28(5):27‑33. (In Russ.)
https://doi.org/10.17116/profmed20252805127

Recommended articles:
Pathogenetic inte­rrelations of hypo­gonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21

References:

  1. Erdes ShF, Rebrov AP, Dubinina TV, et al. Spondyloarthritis: modern terminology and definitions. Terapevticheskii arkhiv. 2019;91(5):84-88. (In Russ.). https://doi.org/10.26442/00403660.2019.05.000208
  2. Korsakova YuL, Korotaeva TV, Loginova EIu, et al. The relationship between obesity, cardiometabolic disorders and disease activityin psoriatic arthritis patients: data from the Russian register. Terapevticheskii arkhiv. 2021;93(5):573-580. (In Russ.). https://doi.org/10.26442/00403660.2021.05.200789
  3. Loginova EYu, Korotaeva TV, Gubar EE, et al. 2-years outcomes of the treat-to-target strategy in early psoriatic arthritis. Nauchno-prakticheskaya revmatologia. 2022;60(5):580-586. (In Russ.). https://doi.org/10.47360/1995-4484-2022-580-586
  4. Gossec L, Kerschbaumer A, Ferreira RJO, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the Rheumatic Diseases. 2024;83(6):706-719.  https://doi.org/10.1136/ard-2024-225531
  5. Merola JF, Tian H, Patil D, et al. Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States. Journal of the American Academy of Dermatology. 2022;86(4):748-757.  https://doi.org/10.1016/j.jaad.2021.09.019
  6. Panevin TS, Rozhivanov RV, Zotkin EG, et al. Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics. Terapevticheskii arkhiv. 2024;96(5):486-493. (In Russ.). https://doi.org/10.26442/00403660.2024.05.202704
  7. Panevin TS, Korotaeva TV, Erdes SF, et al. Clinical and instrumental characteristics of psoriatic arthritis in men depending on testosterone levels. Nauchno-prakticheskaya revmatologia. 2024;62(6):627-632. (In Russ.). https://doi.org/10.47360/1995-4484-2024-627-632
  8. Dedov II, Mokrysheva NG, Melnichenko GA, et al. Draft of Russian clinical practice guidelines «Male hypogonadism». Ozhirenie i metabolizm. 2021;18(4):496-507. (In Russ.). https://doi.org/10.14341/omet12817
  9. Zheng JB, Liang QF, Li JH, et al. Longitudinal Trends of AMS and IIEF-5 Scores in Randomly-Selected Community Men 40 to 80 Years Old: Preliminary Results. Journal of Sexual Medicine. 2019;16(10):1567-1573. https://doi.org/10.1016/j.jsxm.2019.07.017
  10. Baillargeon J, Al Snih S, Raji MA, et al. Hypogonadism and the risk of rheumatic autoimmune disease. Clinical Rheumatology. 2016;35(12):2983-2987. https://doi.org/10.1007/s10067-016-3330-x
  11. Malkin CJ, Pugh PJ, Jones RD, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. Journal of Clinical Endocrinology and Metabolism. 2004;89(7):3313-3318. https://doi.org/10.1210/jc.2003-031069
  12. Zarotsky V, Huang MY, Carman W, et al. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014;2(6):819-834.  https://doi.org/10.1111/andr.274
  13. Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health and Quality of Life Outcomes. 2003;1:15.  https://doi.org/10.1186/1477-7525-1-15
  14. Moore C, Huebler D, Zimmermann T, et al. The Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. European Urology. 2004;46(1):80-87.  https://doi.org/10.1016/j.eururo.2004.01.009
  15. Morley JE, Perry HM 3rd, Kevorkian RT, et al. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53(4):424-429.  https://doi.org/10.1016/j.maturitas.2005.07.004
  16. Conway K, Heinemann LA, Giroudet C, et al. Harmonized French version of the Aging Males’ Symptoms Scale. Aging Male. 2003;6(2):106-109. 
  17. Rosen RC, Araujo AB, Connor MK, et al. Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls [published correction appears in Aging Male. 2009;12(4):157]. Aging Male. 2009;12(2-3):77-85.  https://doi.org/10.1080/13685530903184043
  18. Kang J 2nd, Ham BK, Oh MM, et al. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean Journal of Urology. 2011;52(6):416-420.  https://doi.org/10.4111/kju.2011.52.6.416
  19. Clapauch R, Braga DJ, Marinheiro LP, et al. Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires. Arquivos Brasileiros de Endocrinologia e Metabologia. 2008;52(9):1439-1447. https://doi.org/10.1590/s0004-27302008000900006
  20. Basar MM, Aydin G, Mert HC, et al. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology. 2005;66(3):597-601.  https://doi.org/10.1016/j.urology.2005.03.060
  21. Kondrashov AA, Shostak NA. Composition of the body in male patients with rheumatoid arthritis with account of androgenic status. Nauchcno-prakticheskaya revmatologia. 2021;59(6):700-707. (In Russ.). https://doi.org/10.47360/1995-4484-2021-700-707
  22. Allam JP, Bunzek C, Schnell L, et al. Low serum testosterone levels in male psoriasis patients correlate with disease severity. European Journal of Dermatology. 2019;29(4):375-382.  https://doi.org/10.1684/ejd.2019.3605

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.